BRCA相关ATM介导的DNA双链断裂修复与卵巢衰老
本综述检索PubMed至2019年5月的文献,评估BRCA功能与ATM介导的DNA双链断裂修复在卵巢衰老中的作用。实验室、转化和临床证据提示BRCA相关ATM介导的DNA双链断裂修复功能可能是卵巢衰老的调节因素,其年龄相关下降可能损害卵母细胞健康。
要点
- BRCA1功能与ATM介导的DNA双链断裂修复在多种物种(包括人类)卵母细胞中随年龄减弱。
- BRCA突变女性及BRCA突变小鼠原始卵泡数量减少,卵母细胞DNA双链断裂积累加速。
- BRCA1突变女性通常卵巢储备较低且绝经较早。
核心结论
- BRCA相关ATM介导的DNA双链断裂修复功能可能是卵巢衰老的调节因素。
- 该通路年龄相关下降可能损害卵母细胞健康。
研究设计与样本
- 综述检索PubMed英文文献至2019年5月,排除摘要或会议论文集(除外作者自己的)。
主要发现
- 实验室研究提供稳健可重复证据:BRCA1功能与ATM介导的DNA双链断裂修复在多种物种(包括人类)卵母细胞中随年龄减弱。
- BRCA突变女性及BRCA突变小鼠原始卵泡数量减少,卵母细胞DNA双链断裂积累加速。
- BRCA1突变女性通常卵巢储备较低且绝经较早。
- 实验室证据支持BRCA1及其他ATM介导的DNA双链断裂修复通路成员在减数分裂功能中的关键作用。
- DNA损伤与修复似乎是化疗诱导卵巢衰老的关键特征。
临床怎么用
- 现有数据提示BRCA相关ATM介导的DNA修复通路是卵母细胞衰老调节因素的强候选者。
- 该知识可能为开发靶向治疗以逆转或预防生理性或化疗诱导的卵母细胞衰老创造机会。
- BRCA或类似突变女性可能需要特别接受生育力保存咨询。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oocyte aging has significant clinical consequences, and yet no treatment exists to address the age-related decline in oocyte quality. The lack of progress in the treatment of oocyte aging is due to the fact that the underlying molecular mechanisms are not sufficiently understood. BRCA1 and 2 are involved in homologous DNA recombination and play essential roles in ataxia telangiectasia mutated (ATM)-mediated DNA double-strand break (DSB) repair. A growing body of laboratory, translational and clinical evidence has emerged within the past decade indicating a role for BRCA function and ATM-mediated DNA DSB repair in ovarian aging. OBJECTIVE AND RATIONALE: Although there are several competing or complementary theories, given the growing evidence tying BRCA function and ATM-mediated DNA DSB repair mechanisms in general to ovarian aging, we performed this review encompassing basic, translational and clinical work to assess the current state of knowledge on the topic. A clear understanding of the mechanisms underlying oocyte aging may result in targeted treatments to preserve ovarian reserve and improve oocyte quality. SEARCH METHODS: We searched for published articles in the PubMed database containing key words, BRCA, BRCA1, BRCA2, Mutations, Fertility, Ovarian Reserve, Infertility, Mechanisms of Ovarian Aging, Oocyte or Oocyte DNA Repair, in the English-language literature until May 2019. We did not include abstracts or conference proceedings, with the exception of our own. OUTCOMES: Laboratory studies provided robust and reproducible evidence that BRCA1 function and ATM-mediated DNA DSB repair, in general, weakens with age in oocytes of multiple species including human. In both women with BRCA mutations and BRCA-mutant mice, primordial follicle numbers are reduced and there is accelerated accumulation of DNA DSBs in oocytes. In general, women with BRCA1 mutations have lower ovarian reserves and experience earlier menopause. Laboratory evidence also supports critical role for BRCA1 and other ATM-mediated DNA DSB repair pathway members in meiotic function. When laboratory, translational and clinical evidence is considered together, BRCA-related ATM-mediated DNA DSB repair function emerges as a likely regulator of ovarian aging. Moreover, DNA damage and repair appear to be key features in chemotherapy-induced ovarian aging. WIDER IMPLICATIONS: The existing data suggest that the BRCA-related ATM-mediated DNA repair pathway is a strong candidate to be a regulator of oocyte aging, and the age-related decline of this pathway likely impairs oocyte health. This knowledge may create an opportunity to develop targeted treatments to reverse or prevent physiological or chemotherapy-induced oocyte aging. On the immediate practical side, women with BRCA or similar mutations may need to be specially counselled for fertility preservation.
引用
- Turan V, Oktay K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum Reprod Update. 2020. PMID: 31822904. doi:10.1093/humupd/dmz043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。